Instruction for use: Clenbuterol Sopharma

Active substance Clenbuterol

ATX Code R03CC13 Clenbuterol

Pharmacotherapeutic group:

Bronchodilator agent - a selective beta2-agonists [beta-adrenergic agonist]

The nosological classification (ICD-10)

J44 Other chronic obstructive pulmonary disease

Allergic bronchitis, Bronchitis asthma, Asthmatic bronchitis, wheeze bronchitis, Bronchitis is an obstructive, bronchi disease, Shortness of sputum in acute and chronic respiratory diseases, Cough in inflammatory diseases of the lung and bronchus, Reversible airflow obstruction, Reversible obstructive airway disease, Obstructive bronchitis disease, Obstructive lung disease, Obstructive bronchitis, Spastic bronchitis, Chronic lung disease, Chronic nonspecific lung diseases, Chronic obstructive pulmonary disease, Chronic obstructive bronchitis, Chronic obstructive airway disease, Chronic obstructive pulmonary disease, Restrictive lung pathology

J44.9 Chronic obstructive pulmonary disease, unspecified

Obstructive pulmonary diseases, Bronchial obstruction, bronchial obstruction, Exacerbation of chronic obstructive pulmonary disease, reversible airflow obstruction, Reversible airway obstruction, panbronchiolitis, Panbronhit, COPD, Chronic pulmonary infection, Chronic infection of the lower respiratory tract, Chronic obstructive pulmonary disease, Chronic obstructive pneumonia, Chronic lung disease, Chronic obstructive pulmonary disease, Chronic bronchopulmonary disease, Chronic broncho-pulmonary diseases, Airway obstruction

J45 Asthma

Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma

Structure and Composition

Tablets 1 tab.

active substance:

clenbuterol hydrochloride 0.02 mg

Excipients: lactose monohydrate - 70 mg; wheat starch - 31.48 mg; MCC - 48.5 mg; colloidal silicon dioxide - 2 mg; magnesium stearate - 2 mg; povidone (Povidone K25) - 6 mg.

pharmachologic effect

bronchodilatory, sekretoliticheskoe.

Dosing and Administration

Inside.

Adults: 0.02 mg (1 tab.) 2 times a day, morning and evening. The maintenance dose of 0.01 mg (1/2 tab.) 2 times a day. In more severe conditions in the first days of the prescribed 0.04 mg (2 tab.) 2 times a day, morning and evening. After improving the patient's dose should be reduced.

Children: from 6 to 12 years - 0.01 mg (1/2 tab.) 2 times a day, morning and evening; over 12 years - 0.01 mg (1/2 tab.) 2-3 times per day or 0.02 mg (1 tab.) 2 times a day, morning and evening.

release Form

Tablets of 0.02 mg. The blister of PVC film / aluminum foil of 10 pieces. 5 blisters in a cardboard pack.

Storage conditions

In a dry, dark place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

The shelf life

3 years.

Do not use beyond the expiration date printed on the package.

Available on prescription